Pittsburgh, PA28 Active Studies

Ankylosing Spondylitis Clinical Trials in Pittsburgh, PA

Find 28 actively recruiting ankylosing spondylitis clinical trials in Pittsburgh, PA. Connect with local research sites and explore new treatment options.

28
Active Trials
24
Sponsors
20,848
Enrolling

Recruiting Ankylosing Spondylitis Studies in Pittsburgh

About Ankylosing Spondylitis Clinical Trials in Pittsburgh

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 28 ankylosing spondylitis clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 20,848 participants. Research is being sponsored by JHSPH Center for Clinical Trials, University of California, San Francisco, University of Pittsburgh and 21 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Pittsburgh — FAQ

Are there ankylosing spondylitis clinical trials in Pittsburgh?

Yes, there are 28 ankylosing spondylitis clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 28 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 17, 2026 from ClinicalTrials.gov